IRIS

In vitro and in vivo activity of the VEGF receptor inhibitor PAZOPANIB (GW786034) in Multiple Myeloma: Therapeutic implications / Podar, K; Tonon, G; Abtahi, D; Catley, Lp; Tai, Yt; Legouill, S; Yasui, H; Sattler, M; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc. - In: CANCER RESEARCH. - ISSN 0008-5472. - 66:8(2006).

In vitro and in vivo activity of the VEGF receptor inhibitor PAZOPANIB (GW786034) in Multiple Myeloma: Therapeutic implications

Tonon, G;
2006-01-01
2006
Inglese
CANCER RESEARCH
AMER ASSOC CANCER RESEARCH
615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
66
8
WOS:000454608805160
Esperti anonimi
Not applicable
Sì
13
info:eu-repo/semantics/conferenceObject
In vitro and in vivo activity of the VEGF receptor inhibitor PAZOPANIB (GW786034) in Multiple Myeloma: Therapeutic implications / Podar, K; Tonon, G; Abtahi, D; Catley, Lp; Tai, Yt; Legouill, S; Yasui, H; Sattler, M; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc. - In: CANCER RESEARCH. - ISSN 0008-5472. - 66:8(2006).
none
274
4 Contributo in Atti di Convegno (Proceeding)::4.2 Abstract in Atti di convegno
Podar, K; Tonon, G; Abtahi, D; Catley, Lp; Tai, Yt; Legouill, S; Yasui, H; Sattler, M; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc...espandi
4.2 Abstract in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/172365
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact